HCA — HCA Healthcare Cashflow Statement
0.000.00%
- $80.73bn
- $127.33bn
- $70.60bn
- 94
- 62
- 80
- 93
Annual cashflow statement for HCA Healthcare, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 4,387 | 7,721 | 6,834 | 6,091 | 6,657 |
Depreciation | |||||
Non-Cash Items | 846 | -1,112 | -129 | 720 | 651 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 1,278 | -503 | -1,152 | -457 | -106 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Payable / Accrued Expenses | |||||
Cash from Operating Activities | 9,232 | 8,959 | 8,522 | 9,431 | 10,514 |
Capital Expenditures | -2,835 | -3,577 | -4,395 | -4,744 | -4,875 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -558 | 934 | 1,006 | -573 | -58 |
Acquisition of Business | |||||
Sale of Business | |||||
Change in Net Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -3,393 | -2,643 | -3,389 | -5,317 | -4,933 |
Financing Cash Flow Items | -866 | -1,071 | -1,290 | -917 | -1,055 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -4,677 | -6,655 | -5,656 | -4,094 | -4,582 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 1,172 | -342 | -543 | 27 | 998 |